Advancements in Tuberculosis Detection: A Comprehensive Review of Contemporary Diagnostic Strategies
OthersPage Navigation
Introduction
With the persistent global burden of Tuberculosis (TB), early and accurate detection remains a cornerstone in combating this disease. The recent years have seen significant advancements in TB diagnostic strategies, enhancing the efficiency of detection and management.
GeneXpert MTB/RIF
Introduced by Cepheid, the GeneXpert MTB/RIF system has revolutionized TB diagnosis. This automated, cartridge-based nucleic acid amplification test provides results within two hours, identifying Mycobacterium tuberculosis complex and rifampicin resistance simultaneously.
Line Probe Assays
World Health Organization-endorsed Line Probe Assays (LPAs) have been instrumental in detecting drug-resistant TB. LPAs allow for rapid identification of resistance to rifampicin and isoniazid, the two most potent first-line anti-TB drugs.
Next-Generation Sequencing
Next-Generation Sequencing (NGS) provides comprehensive genetic information, enabling the detection of drug resistance and strain typing. NGS's high-throughput capabilities make it a promising tool for TB diagnostics.
Conclusion
These advancements in TB detection have propelled us closer to the goal of TB elimination. However, the challenge of accessibility and cost-effectiveness in resource-limited settings persists. Continued innovation and investment in diagnostic strategies are essential to curb the global TB epidemic.
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup
2.
Olaparib-Abiraterone in mCRPCs Selected by Biomarkers Outperforms Each Agent by Itself.
3.
Top 10 questions about breast cancer answered
4.
Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study
5.
For some patients with bladder cancer that has invaded the muscle, trimodality therapy is just as effective as radical cystectomy.
1.
Single-Cell Lineage Tracing in Hematology: Decoding the Cellular Blueprint of Blood Disorders
2.
Unlocking the Potential of Red Bone Marrow in the Formation of Blood Cells
3.
Cancer Vaccines in Solid Tumors: Current Landscape, Mechanisms, and Clinical Implications
4.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
5.
Intratumoral Drug Distribution as a Determinant of Therapeutic Success
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
2.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
3.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge